JIANGSU HANSOH PHARMACEUTICAL CO., LTD.
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 86 Total Citation Count
- Oct 30, 2007 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9512121 [1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereofMar 04, 14Dec 06, 16[A61K, C07D]
9388133 Pyrrole sulfonamide derivative, preparation method for same, and medical application thereofNov 06, 13Jul 12, 16[C07D]
9273052 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereofJul 26, 11Mar 01, 16[A61K, C07D]
9233954 Organic amine salts of Azilsartan, preparation method and use thereofJan 11, 12Jan 12, 16[A61K, C07D, C07C]
8951993 Phosphorus containing compounds as protein kinase inhibitorsFeb 22, 12Feb 10, 15[A61K, C07F]
8691822 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereofSep 14, 10Apr 08, 14[A61K, C07D, A61P]
8642545 Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereofNov 24, 08Feb 04, 14[C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0303,518 Methods of Inhibiting the Catalytic Activity of a Protein Kinase and of Treating a Protein Kinase Related DisorderAbandonedSep 27, 12Nov 14, 13[A61K, C12N, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.